SG11201502897VA - Prdm14 and fam19a4, molecular diagnostic markers for hpv-induced invasive cancers and their high-grade precursor lesions - Google Patents

Prdm14 and fam19a4, molecular diagnostic markers for hpv-induced invasive cancers and their high-grade precursor lesions

Info

Publication number
SG11201502897VA
SG11201502897VA SG11201502897VA SG11201502897VA SG11201502897VA SG 11201502897V A SG11201502897V A SG 11201502897VA SG 11201502897V A SG11201502897V A SG 11201502897VA SG 11201502897V A SG11201502897V A SG 11201502897VA SG 11201502897V A SG11201502897V A SG 11201502897VA
Authority
SG
Singapore
Prior art keywords
fam19a4
prdm14
hpv
diagnostic markers
molecular diagnostic
Prior art date
Application number
SG11201502897VA
Inventor
Christophorus Joannes Lambertus Maria Meijer
Petrus Josephus Ferdinandus Snijders
Renske Daniëla Maria Steenbergen
Original Assignee
Self Screen Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Self Screen Bv filed Critical Self Screen Bv
Publication of SG11201502897VA publication Critical patent/SG11201502897VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/708Specific hybridization probes for papilloma
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11201502897VA 2012-10-12 2013-10-14 Prdm14 and fam19a4, molecular diagnostic markers for hpv-induced invasive cancers and their high-grade precursor lesions SG11201502897VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12188377 2012-10-12
PCT/NL2013/050729 WO2014058321A1 (en) 2012-10-12 2013-10-14 Prdm14 and fam19a4, molecular diagnostic markers for hpv-induced invasive cancers and their high-grade precursor lesions

Publications (1)

Publication Number Publication Date
SG11201502897VA true SG11201502897VA (en) 2015-05-28

Family

ID=47049031

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201502897VA SG11201502897VA (en) 2012-10-12 2013-10-14 Prdm14 and fam19a4, molecular diagnostic markers for hpv-induced invasive cancers and their high-grade precursor lesions

Country Status (21)

Country Link
US (1) US9890432B2 (en)
EP (2) EP2906716B1 (en)
JP (1) JP6703400B2 (en)
KR (1) KR102143241B1 (en)
CN (2) CN106282342A (en)
AU (1) AU2013330509B2 (en)
BR (1) BR112015008257B1 (en)
CA (1) CA2887544C (en)
DK (1) DK2906716T5 (en)
EA (1) EA032860B1 (en)
ES (1) ES2664923T3 (en)
HK (1) HK1209460A1 (en)
MX (1) MX361211B (en)
MY (1) MY183325A (en)
NO (1) NO2906716T3 (en)
NZ (1) NZ708027A (en)
PH (1) PH12015500808B1 (en)
PT (1) PT2906716T (en)
SG (1) SG11201502897VA (en)
WO (1) WO2014058321A1 (en)
ZA (1) ZA201503276B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113564250A (en) * 2014-10-17 2021-10-29 科罗拉多大学董事会法人团体 Biomarkers for head and neck cancer and methods of use thereof
EP3135768A1 (en) * 2015-08-26 2017-03-01 Self-screen B.V. Zic1 and ghsr, molecular diagnostic markers for hpv-induced invasive cancers, nonhpv-induced gynaecological and anogenital cancers and their high-grade precursor lesions
CN110753761A (en) * 2017-03-10 2020-02-04 塞尔夫斯库林有限公司 Methylation classifiers for detection of HPV-induced invasive, non-HPV-induced gynecological and anogenital cancers and their higher precursor lesions
US20190112673A1 (en) 2017-05-10 2019-04-18 Genomic Vision Association between integration of high-risk hpv genomes detected by molecular combing and the severity and/or clinical outcome of cervical lesions
BR112019023555A2 (en) * 2017-05-11 2020-06-02 Inovio Pharmaceuticals, Inc. CLINICAL AND IMMUNOLOGICAL BIOMARKERS FOR HIGH DEGREE CERVICAL DYSPLASIA REGULATIONS AND DEPURATION OF HPV 16 AND HPV 18 INFECTION AFTER IMMUNOTHERAPY
CN107287294A (en) * 2017-06-14 2017-10-24 广州中心法则生物科技有限公司 A kind of detection primer, probe, kit and its application of cervical cancer-related genes methylation
WO2019022605A1 (en) 2017-07-25 2019-01-31 Stichting Vumc Micro rna-based methods and compositions for detection of hpv-induced invasive cancers, and their high-grade precursor lesions
WO2019069229A1 (en) * 2017-10-02 2019-04-11 Neuracle Science Co., Ltd. Use of anti-family with sequence similarity 19, member a5 antibodies for the treatment and diagnosis of mood disorders
CN108060231A (en) * 2018-02-24 2018-05-22 韩林志 For the primer pair, kit and method of cervical cancer gene FAM19A4, miR-124-2 DNA methylation assay
WO2020109866A1 (en) 2018-11-30 2020-06-04 Genomic Vision Association between integration of viral as hpv or hiv genomes and the severity and/or clinical outcome of disorders as hpv associated cervical lesions or aids pathology
CN114214415A (en) * 2021-12-29 2022-03-22 广州安必平医药科技股份有限公司 Primer probe combination for methylation detection of cervical cancer related genes and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2721356C (en) 2008-04-14 2019-11-12 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoeen Patieentenzorg Mal, a molecular diagnostic marker for hpv-induced invasive cancers and their high-grade precursor lesions
US20130129668A1 (en) * 2011-09-01 2013-05-23 The Regents Of The University Of California Diagnosis and treatment of arthritis using epigenetics
PL2756099T3 (en) 2011-09-15 2017-12-29 Self-Screen B.V. Method to detect HPV-induced cervical cancer

Also Published As

Publication number Publication date
DK2906716T3 (en) 2018-04-23
CN104870653A (en) 2015-08-26
PT2906716T (en) 2018-04-13
EP3106524A1 (en) 2016-12-21
PH12015500808A1 (en) 2015-06-08
KR102143241B1 (en) 2020-08-11
EP2906716B1 (en) 2018-01-31
ES2664923T3 (en) 2018-04-24
CA2887544C (en) 2021-03-16
EA201590724A1 (en) 2015-09-30
BR112015008257B1 (en) 2022-05-24
EA032860B1 (en) 2019-07-31
MY183325A (en) 2021-02-18
DK2906716T5 (en) 2018-05-07
CA2887544A1 (en) 2014-04-17
JP2015532108A (en) 2015-11-09
BR112015008257A2 (en) 2017-11-28
CN106282342A (en) 2017-01-04
ZA201503276B (en) 2016-10-26
US9890432B2 (en) 2018-02-13
KR20150084868A (en) 2015-07-22
WO2014058321A1 (en) 2014-04-17
JP6703400B2 (en) 2020-06-03
MX361211B (en) 2018-11-30
AU2013330509B2 (en) 2019-01-17
MX2015004556A (en) 2015-10-22
NZ708027A (en) 2019-01-25
PH12015500808B1 (en) 2015-06-08
NO2906716T3 (en) 2018-06-30
AU2013330509A1 (en) 2015-05-28
EP2906716A1 (en) 2015-08-19
US20150284815A1 (en) 2015-10-08
HK1209460A1 (en) 2016-04-01

Similar Documents

Publication Publication Date Title
ZA201503276B (en) Prdm14 and fam19a4, molecular diagnostic markers for hpv-induced invasive cancers and their high-grade precursor lesions
ZA201508689B (en) Molecular diagnostic test for cancer
GB2500784B (en) Lung Biopsy Needle
HRP20181726T1 (en) Non-invasive cancer diagnosis
SG11201504023SA (en) Molecular diagnostic test for cancer
EP2864500A4 (en) Molecular malignancy in melanocytic lesions
IL229681A0 (en) Molecular diagnostic test for cancer
PT2829881T (en) Diagnostic for colorectal cancer
EP2661231A4 (en) Minimally invasive laparoscopic retractor
HK1251622A1 (en) Zic1 and ghsr, molecular diagnostic markers for hpv-induced invasive cancers, nonhpv-induced gynaecological and anogenital cancers and their high-grade precursor lesions
EP2797605A4 (en) Targeted self-assembly 0f functionalized carbon nanotubes on tumors
EP2938277A4 (en) Trocar
HK1214611A1 (en) Ly75 as cancer therapeutic and diagnostic target ly75
EP2617413A4 (en) Nano-vehicle derived from tumor tissue, and cancer vaccine using same
ZA201408120B (en) Diagnostic gene marker panel for colorectal cancer
EP2885429A4 (en) Diagnostic markers of indolent prostate cancer
EP2873726A4 (en) Antitumor agent, marker for tumor detection, and oral vaccine agent
EP2851007A4 (en) Trocar
GB201414102D0 (en) Colorectal cancer diagnosis and indication marker
GB2506510B (en) Multiple lumen hose
PT2831590T (en) New lung cancer molecular markers
Adderley Woman
GB201019610D0 (en) TB Diagnosis
AU345285S (en) Surgical dissector
GB201011820D0 (en) Non-muscle-invasive bladder cancer diagnostic